HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WARNER-LAMBERT SEEKS CATEGORY I STATUS FOR LISTERINE AS ORAL ANTISEPTIC

This article was originally published in The Rose Sheet

Executive Summary

WARNER-LAMBERT SEEKS CATEGORY I STATUS FOR LISTERINE AS ORAL ANTISEPTIC in an Aug. 5 submission to FDA. The company is asking for Category I status for both Listerine and Cool Mint Listerine based on in vitro and in vivo data supporting the antibacterial efficacy of the mouthwashes. Both products, Warner-Lambert noted, contain a "fixed combination" of four essential oils -- eucalyptol (.092%), menthol (.042%), methyl salicylate (.060%) and thymol (.064%) -- in hydroalcoholic vehicles.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS000777

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel